MAPT and Alzheimer disease: Importantly, both HDAC6 inhibitors caused large and significant 50–60% decreases (p = 0.002 for ACY-1083 and p < 0.001 for ACY-775) in insoluble rat tau in the AD-tau-seeded cultures (Fig. 2A,C,D,F).